Non-bacterial thrombotic endocarditis overview: Difference between revisions
Homa Najafi (talk | contribs) No edit summary |
Aisha Adigun (talk | contribs) |
||
| Line 5: | Line 5: | ||
==Historical Perspective== | ==Historical Perspective== | ||
The association between [[Thrombosis|thromboembotic events]] and [[malignancy]] was made by Armand Trousseau in the year 1865. In 1926, Dr. Benjamin Sacks and Dr. Emmanuel Libman published cases of "valvular masses" that were examined clinically and during [[autopsies]] and found to be free of all [[Microorganism|microorganisms]]. These masses were initially named "indeterminate [[endocarditis]]". | |||
==Classification== | ==Classification== | ||
Revision as of 21:34, 22 August 2020
|
non-bacterial thrombotic endocarditis |
|
Differentiating non-bacterial thrombotic endocarditis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Non-bacterial thrombotic endocarditis overview On the Web |
|
American Roentgen Ray Society Images of Non-bacterial thrombotic endocarditis overview |
|
Risk calculators and risk factors for Non-bacterial thrombotic endocarditis overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aisha Adigun, B.Sc., M.D.[2]
Overview
Historical Perspective
The association between thromboembotic events and malignancy was made by Armand Trousseau in the year 1865. In 1926, Dr. Benjamin Sacks and Dr. Emmanuel Libman published cases of "valvular masses" that were examined clinically and during autopsies and found to be free of all microorganisms. These masses were initially named "indeterminate endocarditis".